Google Parent Plans to Use AI Prowess to Invent Medicines
- Isomorphic Labs forms with DeepMind head Hassabis as CEO
- New firm is third futuristic health venture for Google parent
Photographer: Chris Ratcliffe/Bloomberg
This article is for subscribers only.
Alphabet Inc. said it has created a new company, called Isomorphic Labs, to use artificial intelligence for drug discovery.
The new division was spun out of DeepMind, the London research lab of Google’s parent company. DeepMind’s algorithms have made huge advances in predicting the shapes of proteins, a technology that could speed up the development of new drugs and upend the pharmaceutical industry.